Author's Contributions
Central banks at odds: How are Fed and ECB reacting to the trade conflict?
Trump’s customs policy and the trade conflict also pose new challenges for central banks. However, while the ECB has room to cut interest rates in order to support the economy, the Fed must exercise caution in the USA. Higher tariffs also threaten to push up inflation again.
However, US President Donald Trump does not like the Fed’s course at all. His attacks on Fed Chairman Jerome Powell are fuelling concerns about the central bank’s independence. Even though Trump has recently backed down slightly, his comments are once again unsettling the markets.
Environmental stocks: How is the sector faring in the current volatile environment?
The first quarter had a few surprises in store for the markets. The US tariff announcements shook the markets to the core and caused a volatile stock market environment. The environmental technology sector was not spared either. What is the outlook for the sector? We asked fund managers Clemens Klein and Alexander Weiß in a double interview.
Get Flexible – YOU INVEST funds are starting up again
From March, the YOU INVEST funds will be gradually reorganized. With the renaming to YOU INVEST FLEXIBLE, the funds will not only have a new name but also a more flexible investment strategy and new opportunities through additional diversified sub-funds in which the funds of the YOU INVEST family can invest from the realignment onwards. You can find all the information on the changeover in today’s blog post 👉
Investment View | February 2025
What’s happening on the markets? In our Investment View, the experts of our Investment Division regularly provide insights of current market events and their opinion on the various asset classes.
The Tariff Man
Last Sunday, the US government announced new tariffs on goods from Canada, Mexico and China, only to suspend them again shortly afterwards. How might the trade conflict develop? Is the EU also threatened with new tariffs?
Pharmaceutical Companies Increase Sales, Focus on Innovation and Acquisitions
The pharmaceutical industry was able to further increase its sales in the last quarter. The biggest players in the sector are relying on acquisitions and innovations – including the increased use of AI. However, things could get more uncomfortable for pharmaceutical companies in the US market: the future US Secretary of Health and Human Services, Rober F. Kennedy Jr., is considered a critic of the industry and has already spoken out in favor of capping drug prices.
Eastern Europe: Economies expected to outperform Euro Area
Weakening growth in the eurozone has been an issue on the markets for some time now. In the Central and Eastern European countries, however, this is largely a non-issue. According to forecasts, the region is also likely to grow faster than the eurozone this year. Private consumption in particular has recently proved to be a growth driver. However, the tense situation in German industry is causing concern.
Economic outlook: soft landing with risks attached
On the stock markets, the focus is shifting back to the downside risks. Nevertheless, there are still hopes that inflation will gradually fall and that there will be no recession. But how realistic are the hopes for this “soft landing” of the economy and how can investors position themselves in the current environment?
US tech stocks: Mixed feelings after earnings figures
The shares of the major US technology companies, which had performed very well for a long time, have also fallen recently. The latest half-year figures left the market with mixed feelings: although the figures were largely as expected, there were hardly any increases in profit expectations. Nevertheless, the outlook remains positive, which for fund manager Bernhard Ruttenstorfer has several reasons.
Losses on the stock markets: an overview of the reasons and consequences
There was little to cheer about on the stock markets at the start of the week: there were significant price losses in both Europe and the USA and the Japanese Nikkei-225 recorded one of the biggest daily losses in its history. What were the reasons for Monday’s sharp sell-off, what impact could the latest events have on the markets and what will happen with the increasingly weak economy?